Whole Genome Sequencing in Circulating Myeloma Cells: A Patient Survey of Value, Access, and Precision Promise
About
This survey asks your opinion on a new type of genetic testing called whole genome sequencing (WGS) that could help doctors choose better treatments for your myeloma based on your cancer’s unique DNA.
8 minutes
HealthTree Foundation
Contact Information
For any questions or concerns regarding the study, participants can contact HealthTree Patient Navigators at support@healthtree.org.